Sight Sciences, Inc.
SGHT
$3.63
$0.164.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 77.36M | 76.05M | 76.30M | 78.11M | 79.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 77.36M | 76.05M | 76.30M | 78.11M | 79.87M |
| Cost of Revenue | 10.70M | 10.61M | 11.15M | 11.20M | 11.58M |
| Gross Profit | 66.67M | 65.44M | 65.15M | 66.91M | 68.29M |
| SG&A Expenses | 87.36M | 92.54M | 95.98M | 98.79M | 100.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 111.66M | 118.61M | 124.99M | 127.78M | 130.40M |
| Operating Income | -34.30M | -42.56M | -48.68M | -49.67M | -50.53M |
| Income Before Tax | -38.42M | -46.07M | -48.72M | -49.14M | -51.27M |
| Income Tax Expenses | 10.00K | 40.00K | 285.00K | 260.00K | 236.00K |
| Earnings from Continuing Operations | -38.43 | -46.11 | -49.01 | -49.40 | -51.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.43M | -46.11M | -49.01M | -49.40M | -51.51M |
| EBIT | -34.30M | -42.56M | -48.68M | -49.67M | -50.53M |
| EBITDA | -33.81M | -42.01M | -48.08M | -49.00M | -49.82M |
| EPS Basic | -0.74 | -0.90 | -0.96 | -0.98 | -1.03 |
| Normalized Basic EPS | -0.43 | -0.53 | -0.60 | -0.61 | -0.62 |
| EPS Diluted | -0.74 | -0.90 | -0.96 | -0.98 | -1.03 |
| Normalized Diluted EPS | -0.43 | -0.53 | -0.60 | -0.61 | -0.62 |
| Average Basic Shares Outstanding | 208.58M | 206.29M | 204.25M | 202.33M | 200.53M |
| Average Diluted Shares Outstanding | 208.58M | 206.29M | 204.25M | 202.33M | 200.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |